Does multimodal treatment of ADHD decrease other diagnoses?

Lily Hechtman, Joy Etcovitch, Robert Platt, L. Eugene Arnold, Howard B. Abikoff, Jeffery H. Newcorn, Betsy Hoza, Stephen P. Hinshaw, Helena C. Kraemer, Karen Wells, Keith Conners, Glen Elliott, Laurence L. Greenhill, Peter S. Jensen, John S. March, Brooke Molina, William E. Pelham, Joanne B. Severe, James M. Swanson, Benedetto VitielloTimothy Wigal

Research output: Contribution to journalArticle

Abstract

Comorbid conditions in children with attention deficit hyperactivity disorder (ADHD) are frequent and can affect treatment response and life course. From the multimodal treatment study of ADHD (MTA), we examined the persistence or development of conditions other than ADHD, e.g. oppositional defiant disorder (ODD), conduct disorder (CD), anxiety, depression, and learning disorder (LD) in 576 children, age 7-9 years, diagnosed rigorously with ADHD, who were randomly assigned to four different treatments for 14 months. The treatment groups were medication management alone (MedMgt), behavioral treatment alone (Beh), the combination (Comb), and community comparison routine care (CC). For the sample as a whole, we found significant decreases from baseline to 14 months in diagnoses of ODD, CD, and anxiety disorder but not LD or mood disorder. The CC group developed significantly more new ODD and retained more baseline ODD than the Comb or MedMgt groups. There were no significant treatment group differences for specific other conditions. Only the Comb group was significantly better than the CC group in reducing total number of disorders and impairment at 14 months in subjects with multiple conditions at baseline. Well-titrated and monitored stimulant medication can decrease ODD and possibly prevent future CD. Combined treatment may be required for the most disturbed children with ADHD who have multiple disorders and severe impairment.

Original languageEnglish (US)
Pages (from-to)273-282
Number of pages10
JournalClinical Neuroscience Research
Volume5
Issue number5-6
DOIs
StatePublished - Dec 1 2005

Keywords

  • ADHD
  • Behavioral treatment
  • Comorbidity
  • Multimodal treatment
  • Outcome

ASJC Scopus subject areas

  • Neuropsychology and Physiological Psychology
  • Neurology
  • Clinical Neurology
  • Psychiatry and Mental health
  • Biological Psychiatry

Fingerprint Dive into the research topics of 'Does multimodal treatment of ADHD decrease other diagnoses?'. Together they form a unique fingerprint.

  • Cite this

    Hechtman, L., Etcovitch, J., Platt, R., Arnold, L. E., Abikoff, H. B., Newcorn, J. H., Hoza, B., Hinshaw, S. P., Kraemer, H. C., Wells, K., Conners, K., Elliott, G., Greenhill, L. L., Jensen, P. S., March, J. S., Molina, B., Pelham, W. E., Severe, J. B., Swanson, J. M., ... Wigal, T. (2005). Does multimodal treatment of ADHD decrease other diagnoses? Clinical Neuroscience Research, 5(5-6), 273-282. https://doi.org/10.1016/j.cnr.2005.09.007